Literature DB >> 7950298

Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length.

T Yamamoto1, S Yamamoto, T Kataoka, T Tokunaga.   

Abstract

A synthetic 30-mer single-stranded oligodeoxyribonucleotide with a hexamer palindrome, AACGTT, induced IFN production and augmented NK activity in murine splenocytes. This effect does not appear to result from an antisense mechanism but rather is due to the palindrome. To clarify the required minimal size of the nucleotide, 10 kinds of 12- to 30-mer nucleotides were examined. Immunostimulatory activity of oligonucleotides 18 bases or more in length was observed and was proportional to the base length, with a maximum of 22-30 bases. On the other hand, the oligonucleotides 16 bases or less in length were not active even if they possessed the palindromic sequence. These results indicate that the immunostimulatory activity of oligonucleotides with certain palindromic sequences requires an oligonucleotide at least 18 bases long.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7950298     DOI: 10.1089/ard.1994.4.119

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN: 1050-5261


  9 in total

Review 1.  Introduction to immunostimulatory DNA sequences.

Authors:  J Van Uden; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  Bacterial DNA as an evolutionary conserved ligand signalling danger of infection to immune cells.

Authors:  K Heeg; T Sparwasser; G B Lipford; H Häcker; S Zimmermann; H Wagner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

4.  Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.

Authors:  C Lavigne; J Yelle; G Sauvé; A G Thierry
Journal:  AAPS PharmSci       Date:  2001

Review 5.  Potential applications of gene therapy in the patient with cancer.

Authors:  P W Szlosarek; A G Dalgleish
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

6.  Investigation of the intracellular stability and formation of a triple helix formed with a short purine oligonucleotide targeted to the murine c-pim-1 proto-oncogene promotor.

Authors:  F Svinarchuk; A Debin; J R Bertrand; C Malvy
Journal:  Nucleic Acids Res       Date:  1996-01-15       Impact factor: 16.971

Review 7.  CpG oligodeoxynucleotides as mucosal adjuvants.

Authors:  Sumiko Iho; Jun-ichi Maeyama; Fumiko Suzuki
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.

Authors:  Jun-ichi Maeyama; Hisakazu Takatsuka; Fumiko Suzuki; Ayumi Kubota; Satomi Horiguchi; Takako Komiya; Ichiroh Shimada; Eri Murata; Youko Osawa; Harukazu Kitagawa; Takasumi Matsuki; Masanori Isaka; Saburo Yamamoto; Sumiko Iho
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

9.  Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro.

Authors:  T Yamamoto; S Yamamoto; T Kataoka; K Komuro; M Kohase; T Tokunaga
Journal:  Jpn J Cancer Res       Date:  1994-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.